TIM-3 therapy for Alzheimer's represents a groundbreaking approach that harnesses immune system mechanisms previously used in cancer treatment to combat one of the most devastating neurodegenerative diseases.Recent research has revealed the potential of TIM-3, a checkpoint molecule, to release microglia—critical immune cells in the brain—thereby enhancing their ability to clear amyloid plaques that contribute to Alzheimer's degeneration.